官方服务：
资源简介：
PDXs of pancreatic cancer were used to study the molecular features of gemcitabine resistance
应用场景：
创建时间：
2021-02-10
相关数据集
NP-18 vs. NP-18AR transcriptional profile upon treatment with TK/GCV
Pancreatic cancer-derived cells NP-18 underwent four rounds of treatment with increasing doses of an adenoviral vector encoding TK enzyme and GCV. Surviving cells were termed NP-18AR and displayed dec
NIAID Data Ecosystem70
Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine. Homo sapiens
BACKGROUND: Therapy resistance remains one of the major challenges to improve the prognosis of patients with pancreatic cancer. Chemoresistant cells, which potentially also display cancer stem cell (C
NIAID Data Ecosystem30
Additional file 4: of Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer
Supplementary Material 2. mRNAs displayed differential expression. (XLS 3137 kb)
Figshare2019-09-12 更新20
NP-18 vs. NP-18AR transcriptional profile upon treatment with TK/GCV. Homo sapiens
Pancreatic cancer-derived cells NP-18 underwent four rounds of treatment with increasing doses of an adenoviral vector encoding TK enzyme and GCV. Surviving cells were termed NP-18AR and displayed dec
NIAID Data Ecosystem40
Whole genome sequencing of gemcitabine evolved E. coli strains
In order to discover evolutionary adaptations E. coli gain to become resistant to gemcitabine, a lab evolution experiment was performed. Three E. coli strains; BW25113, Nissle 1917 and F-18 were evolv
NIAID Data Ecosystem30
